Determinants of immunological evasion and immunocheckpoint inhibition response in non-small cell lung cancer: the genetic front Maria Saigi, Juan J. Alburquerque-Bejar & Montse Sanchez-Cespedes  Oncogene 2019 38 :5921 - 5932; June 28, 2019; 10.1038/s41388-019-0855-x Abstract | Full Text
BRIEF COMMUNICATIONS
CRAF mutations in lung cancer can be oncogenic and predict sensitivity to combined type II RAF and MEK inhibition Amir Noeparast, Philippe Giron, Alfiah Noor, Rajendra Bahadur Shahi, Sylvia De Brakeleer et al.  Oncogene 2019 38 :5933 - 5941; July 08, 2019; 10.1038/s41388-019-0866-7 Abstract | Full Text
ARTICLE
Alterations in Wnt- and/or STAT3 signaling pathways and the immune microenvironment during metastatic progression S. J. Kim, S. Garcia-Recio, C. J. Creighton, C. M. Perou & J. M. Rosen  Oncogene 2019 38 :5942 - 5958; July 09, 2019; 10.1038/s41388-019-0852-0 Abstract | Full Text
Human Papillomavirus 16 oncoprotein E7 retards mitotic progression by blocking Mps1-MAP4 signaling cascade Yu Guo, Xiaojuan Zhang, Quanbin Xu, Fuxing Gong, Xiaoqian Shi et al.  Oncogene 2019 38 :5959 - 5970; June 28, 2019; 10.1038/s41388-019-0851-1 Abstract | Full Text
TBX2 interacts with heterochromatin protein 1 to recruit a novel repression complex to EGR1-targeted promoters to drive the proliferation of breast cancer cells N. T. Crawford, A. J. McIntyre, A. McCormick, Z. C. D’Costa, N. E. Buckley et al.  Oncogene 2019 38 :5971 - 5986; June 28, 2019; 10.1038/s41388-019-0853-z Abstract | Full Text
Identification of a novel EphB4 phosphodegron regulated by the autocrine IGFII/IRA axis in malignant mesothelioma Pierluigi Scalia, Giuseppe Pandini, Vincenzo Carnevale, Antonio Giordano & Stephen J. Williams  Oncogene 2019 38 :5987 - 6001; July 03, 2019; 10.1038/s41388-019-0854-y Abstract | Full Text